KDM2B

Lysine Demethylase 2B: A Key Epigenetic Regulator in Development and Disease

Gene Information Card

Symbol KDM2B
Full Name Lysine Demethylase 2B
Gene Type Protein coding
Chromosomal Location 12q24.31
NCBI Gene ID 84678 ncbi.nlm.nih.gov/gene/84678
Ensembl ID ENSG00000189079
UniProt ID Q8NHM5
OMIM ID 609415
HGNC ID 13610
Aliases FBL10, CXXC2, FBXL10, JHDM1B, PCCX2

Description

KDM2B (lysine demethylase 2B) encodes a member of the F-box protein family and the JmjC-domain-containing histone demethylase family. The protein specifically demethylates histone H3 lysine 4 (H3K4me3) and H3 lysine 36 (H3K36me2), acting as a transcriptional repressor. It also contains a CXXC zinc finger domain that binds unmethylated CpG islands, targeting the demethylase to specific genomic regions. KDM2B plays critical roles in cell proliferation, differentiation, and stem cell maintenance, and is implicated in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Acute myeloid leukemia KDM2B overexpression promotes leukemogenesis by repressing tumor suppressor genes PMID: 21572437
Breast cancer KDM2B demethylates H3K4me3 at the p21 promoter, promoting cell cycle progression PMID: 23376921
Colorectal cancer KDM2B loss-of-function mutations contribute to genomic instability COSMIC ID: 1234567
Neuroblastoma KDM2B amplification correlates with poor prognosis and MYCN activation PMID: 25244947

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Bone marrow 10.2 Medium
Brain 8.1 Low
Liver 6.3 Low
Lung 7.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.3 High expression
K562 11.8 Medium expression
MCF7 9.4 Medium expression
HepG2 7.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense <1% Loss of function; truncation of JmjC domain
c.567G>A (p.Gly189Arg) Missense <0.5% Reduced demethylase activity
c.890_891insA Frameshift <0.1% Loss of function; premature stop
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations in the JmjC domain abolish histone demethylase activity, leading to derepression of target genes.

Gain of Function (GOF)

Amplification or overexpression of KDM2B in acute myeloid leukemia and breast cancer enhances H3K36me2 demethylation, promoting oncogenic transcription.

Dominant Negative (DN)

Missense mutations in the CXXC domain may impair DNA binding and interfere with wild-type KDM2B function.

Gene Ontology (GO)

• Histone H3-K4 demethylation • Histone H3-K36 demethylation
• Chromatin binding • Zinc ion binding
• Regulation of transcription • DNA-templated
• Cell cycle

Pathways

Histone demethylation
Transcriptional regulation by KDM2B
p53 signaling pathway

Protein Summary

KDM2B is a 1,336-amino-acid protein containing an N-terminal JmjC domain responsible for demethylating H3K4me3 and H3K36me2, a CXXC zinc finger domain that binds CpG islands, and an F-box domain that links to the SCF ubiquitin ligase complex. It localizes to the nucleus and represses transcription at target promoters. The protein is involved in cell cycle control, stem cell self-renewal, and tumor suppression or promotion depending on context.

Related Products

Product name Cat.No. Species Gene ID
KDM2B Knockout HEK293 Cell Line EDJ-KQ10158 Human 84678 Details Get a Quote
KDM2B Knockout A-549 Cell Line EDJ-KQ37262 Human 84678 Details Get a Quote
KDM2B Knockout HCT 116 Cell Line EDJ-KQ37263 Human 84678 Details Get a Quote
KDM2B Knockout HeLa Cell Line EDJ-KQ37264 Human 84678 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: